| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |